2017 publications

Ellington MJ, Ekelund O, Aarestrup FM, Canton R, Doumith M, Giske C, Grundman H, Hasman H, Holden MT, et al. The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee. Clin Microbiol Infect. 2017;23(1):2-22

Hsu LY, Holden MTG, Koh TH, Pettigrew KA, Cao D, Hon PY, Sergio DM, Pena E, Ogden BE. (2017) ST3268: A geographically widespread primate MRSA clone. J Antimicrob Chemother. 72:2401-2403. doi: 10.1093/jac/dkx120.

Chow A, Lim VW, Khan A, Pettigrew K, Lye DCB, Kanagasabai K, Phua K, Krishnan P, Ang B, Marimuthu K, Hon PY, Koh J, Leong I, Parkhill J, Hsu LY, Holden MTG. (2017) MRSA transmission dynamics among interconnected acute, intermediate-term, and long-term healthcare facilities in Singapore. Clin Infect Dis. 15;64:S76-S81. doi: 10.1093/cid/cix072.

Price L, MacDonald J, Melone L, Howe T, Flowers P, Currie K, Curran E, Ness V, Waddell D, Sarkis M, McFarland A, Kilpatrick C, Storr J, Twyman A, Allegranzi B, Reilly J S. (2017) Effectiveness of national and subnational infection prevention and control interventions in high-income and upper-middle-income countries: a systematic review. Lancet ID DOI:http://dx.doi.org/10.1016/S1473-3099(17)30479-6

Price L, MacDonald J, Melone L, Howe T, Flowers P, Currie K, Curran E, Ness V, Waddell D, Sarkis M, McFarland A, Kilpatrick C, Storr J, Twyman A, Allegranzi B, Reilly J S. (2017) Effectiveness of national and subnational infection prevention and control interventions in high-income and upper-middle-income countries: a systematic review. Lancet ID DOI:http://dx.doi.org/10.1016/S1473-3099(17)30479-6

Reilly J, Ness V, MacDonald E. (2017) The health visitor role in containing antimicrobial resistance, Journal of Health Visiting, 5(8), pp.386-390.

Storr J, Twyman A, Zingg W, Damani N, Kilpatrick C, Reilly J, Price L, Egger M, Grayson M L, KelleyE, Allegranz B and the WHO Guidelines Development Group (2017) Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations. Antimicrobial Resistance & Infection Control 2017 6:6 Impact factor 5.0